Somapacitan
Approved for a growth disorderHeight measured in peopleBy injectionProtein or enzymeAlso Sogroya
Growth hormone with a tag that makes it cling to a blood protein for a while, so it lasts longer.
A long-acting formulation: an albumin-binding side chain, where reversible albumin binding extends half-life. Approved for adults in 2020 and for children in 2023.
Risks. No boxed warning, but it carries the whole growth hormone warning set: rising pressure inside the skull, a hip growth plate that can slip, worsening scoliosis, diabetes, a higher cancer risk, and sudden death in children with Prader-Willi syndrome.
On this page
- At the growth plate, members only
- Risks and side effects, members only
The rest of this page is for members
What has been measured, in whom, with every source, and what it does to the rest of you. And every article in the library.
Join for $11.99Lifetime · 3 of 10 founding spots left
Tax is added at checkout (VAT/GST where it applies).
Renews every month at the current price plus tax until you cancel. Cancel from your account before the next monthly charge to stop it.
Card purchases are sold and charged by Link (Stripe) under Link's terms and refund policy.
Already a member? Sign in
Educational content, not medical advice. Nothing here is a recommendation to take or stop taking anything — talk to a doctor about your own situation.